Literature DB >> 16973572

The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses.

Peter J Alff1, Irina N Gavrilovskaya, Elena Gorbunova, Karen Endriss, Yuson Chong, Erika Geimonen, Nandini Sen, Nancy C Reich, Erich R Mackow.   

Abstract

Hantaviruses cause two diseases with prominent vascular permeability defects, hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. All hantaviruses infect human endothelial cells, although it is unclear what differentiates pathogenic from nonpathogenic hantaviruses. We observed dramatic differences in interferon-specific transcriptional responses between pathogenic and nonpathogenic hantaviruses at 1 day postinfection, suggesting that hantavirus pathogenesis may in part be determined by viral regulation of cellular interferon responses. In contrast to pathogenic NY-1 virus (NY-1V) and Hantaan virus (HTNV), nonpathogenic Prospect Hill virus (PHV) elicits early interferon responses following infection of human endothelial cells. We determined that PHV replication is blocked in human endothelial cells and that RNA and protein synthesis by PHV, but not NY-1V or HTNV, is inhibited at 2 to 4 days postinfection. The addition of antibodies to beta interferon (IFN-beta) blocked interferon-directed MxA induction by >90% and demonstrated that hantavirus infection induces the secretion of IFN-beta from endothelial cells. Coinfecting endothelial cells with NY-1V and PHV resulted in a 60% decrease in the induction of interferon-responsive MxA transcripts by PHV and further suggested the potential for NY-1V to regulate early IFN responses. Expression of the NY-1V G1 cytoplasmic tail inhibited by >90% RIG-I- and downstream TBK-1-directed transcription from interferon-stimulated response elements or beta-interferon promoters in a dose-dependent manner. In contrast, expression of the NY-1V nucleocapsid or PHV G1 tail had no effect on RIG-I- or TBK-1-directed transcriptional responses. Further, neither the NY-1V nor PHV G1 tails inhibited transcriptional responses directed by a constitutively active form of interferon regulatory factor 3 (IRF-3 5D), and IRF-3 is a direct target of TBK-1 phosphorylation. These findings indicate that the pathogenic NY-1V G1 protein regulates cellular IFN responses upstream of IRF-3 phosphorylation at the level of the TBK-1 complex. These findings further suggest that the G1 cytoplasmic tail contains a virulence element which determines the ability of hantaviruses to bypass innate cellular immune responses and delineates a mechanism for pathogenic hantaviruses to successfully replicate within human endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16973572      PMCID: PMC1617216          DOI: 10.1128/JVI.00508-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling.

Authors:  G Geiss; G Jin; J Guo; R Bumgarner; M G Katze; G C Sen
Journal:  J Biol Chem       Date:  2001-08-10       Impact factor: 5.157

Review 2.  Viruses and interferon: a fight for supremacy.

Authors:  Michael G Katze; Yupeng He; Michael Gale
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

3.  Induction of innate immune response genes by Sin Nombre hantavirus does not require viral replication.

Authors:  Joseph Prescott; Chunyan Ye; Ganes Sen; Brian Hjelle
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 4.  Nuclear/cytoplasmic localization of IRFs in response to viral infection or interferon stimulation.

Authors:  Nancy C Reich
Journal:  J Interferon Cytokine Res       Date:  2002-01       Impact factor: 2.607

5.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.

Authors:  Etienne Meylan; Joseph Curran; Kay Hofmann; Darius Moradpour; Marco Binder; Ralf Bartenschlager; Jürg Tschopp
Journal:  Nature       Date:  2005-09-21       Impact factor: 49.962

6.  Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae.

Authors:  O Vapalahti; A Lundkvist; S K Kukkonen; Y Cheng; M Gilljam; M Kanerva; T Manni; M Pejcoch; J Niemimaa; A Kaikusalo; H Henttonen; A Vaheri; A Plyusnin
Journal:  J Gen Virol       Date:  1996-12       Impact factor: 3.891

Review 7.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 8.  Hantaviruses: a global disease problem.

Authors:  C Schmaljohn; B Hjelle
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

9.  Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon.

Authors:  Friedemann Weber; Anne Bridgen; John K Fazakerley; Hein Streitenfeld; Nina Kessler; Richard E Randall; Richard M Elliott
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure.

Authors:  I N Gavrilovskaya; M Shepley; R Shaw; M H Ginsberg; E R Mackow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

View more
  72 in total

1.  Genetic reassortment between high-virulent and low-virulent Dobrava-Belgrade virus strains.

Authors:  Sina Kirsanovs; Boris Klempa; Renate Franke; Min-Hi Lee; Günther Schönrich; Andreas Rang; Detlev H Kruger
Journal:  Virus Genes       Date:  2010-08-24       Impact factor: 2.332

2.  Hantaan virus nucleocapsid protein stimulates MDM2-dependent p53 degradation.

Authors:  Sun-Whan Park; Myung-Guk Han; Chan Park; Young Ran Ju; Byung-Yoon Ahn; Jungsang Ryou
Journal:  J Gen Virol       Date:  2013-09-01       Impact factor: 3.891

3.  Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.

Authors:  Alison Kell; Mark Stoddard; Hui Li; Joe Marcotrigiano; George M Shaw; Michael Gale
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

4.  The Andes Orthohantavirus NSs Protein Antagonizes the Type I Interferon Response by Inhibiting MAVS Signaling.

Authors:  Jorge Vera-Otarola; Loretto Solis; Fernando Lowy; Valeria Olguín; Jenniffer Angulo; Karla Pino; Nicole D Tischler; Carola Otth; Paula Padula; Marcelo López-Lastra
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

5.  Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches.

Authors:  Erich R Mackow; Elena E Gorbunova; Nadine A Dalrymple; Irina N Gavrilovskaya
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

6.  Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling.

Authors:  Christina F Spiropoulou; César G Albariño; Thomas G Ksiazek; Pierre E Rollin
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

7.  The Hantavirus Glycoprotein G1 Tail Contains Dual CCHC-type Classical Zinc Fingers.

Authors:  D Fernando Estrada; Daniel M Boudreaux; Dalian Zhong; Stephen C St Jeor; Roberto N De Guzman
Journal:  J Biol Chem       Date:  2009-01-29       Impact factor: 5.157

8.  Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus.

Authors:  Tony Schountz; Joseph Prescott; Ann C Cogswell; Lauren Oko; Katy Mirowsky-Garcia; Alejandra P Galvez; Brian Hjelle
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-17       Impact factor: 11.205

9.  Hantaviruses induce antiviral and pro-inflammatory innate immune responses in astrocytic cells and the brain.

Authors:  Ok Sarah Shin; Gabriella Shinyoung Song; Mukesh Kumar; Richard Yanagihara; Ho-Wang Lee; Jin-Won Song
Journal:  Viral Immunol       Date:  2014-06-17       Impact factor: 2.257

10.  Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus.

Authors:  Tobias Manigold; Andrés Mori; Rebecca Graumann; Elena Llop; Valeska Simon; Marcela Ferrés; Francisca Valdivieso; Constanza Castillo; Brian Hjelle; Pablo Vial
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.